These findings highlight that Akt2 signaling is indispensable for tumor-specific CTLs to effectively eliminate cancer cells in the solid TME, and also reveal that Akt isoforms differentially regulate the calcium–calcineurin–NFAT signaling pathway. The gene discussed is AKT2; the disease is cancer.